The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
Indeed, retrospective analyses suggested that impaired glucose tolerance and hyperglycemia appear 3036 months prior pancreatic cancer diagnosis and almost 50% of newly diagnosed pancreatic cancer patients met the criteria for diabetes based on fasting glucose levels [7]
That can be incredibly meaningful, especially for people who have spent years being told, directly or indirectly, that weight is simply a matter of willpower
As Rita Faycurry, RD, Registered Dietitian, explains: "GLP-1 medications like liraglutide and semaglutide are powerful tools, but they work best when patients embrace comprehensive lifestyle changes
A recent Wall Street Journal article explores how recreational athletes, including runners, cyclists, and triathletes, are increasingly using GLP-1 medications to enhance performance by reducing body weight, improving endurance, and accelerating recovery
10.1677/JOE-10-0217 J